Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00682643 · ClinicalTrials.gov registry record · Phase 4
A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 550
- Enrollment target
NCT00682643 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 550 participants.
The verdict
NCT00682643, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 550 participants
- Enrollment target
Study Summary
The purpose of this study is to assess long-term ocular safety of fluticasone furoate nasal spray in adult and adolescent subjects diagnosed with perennial allergic rhinitis.
Interventions
- DRUG fluticasone furoate nasal spray
- DRUG vehicle placebo nasal spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00682643
The ClinicalTrials.gov registry entry for NCT00682643 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which fluticasone furoate nasal spray is the first listed.
NCT00682643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00682643 about?
NCT00682643 is a clinical study titled "A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis". The purpose of this study is to assess long-term ocular safety of fluticasone furoate nasal spray in adult and adolescent subjects diagnosed with perennial allergic rhinitis.
What is the current status of trial NCT00682643?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 550 participants. The study started on 2008-06. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00682643?
The interventions under investigation include: fluticasone furoate nasal spray (DRUG), vehicle placebo nasal spray (DRUG).
Who is sponsoring clinical trial NCT00682643?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.